Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Britons told to keep getting vaccines after some countries suspend AstraZeneca shots

Thu, 11th Mar 2021 13:58

LONDON, March 11 (Reuters) - The UK's medicine regulator
said on Thursday that Britons should keep on getting their
COVID-19 vaccines, including the shot developed by Oxford and
AstraZeneca, after Denmark and some other countries restricted
their use of it.

Denmark is suspending for two weeks the use of AstraZeneca's
vaccine after reports of the formation of blood clots in
some who have been vaccinated, including one death in Denmark,
Danish authorities said.

Norway joined Denmark in halting its roll-out of the shot
after reports of blood clots, while Italy banned a batch of the
vaccine after notifications of some serious adverse effects.

Britain's Medicines and Healthcare Products Regulatory
Agency (MHRA) said it was not confirmed that the reported blood
clot in Denmark was caused by the vaccine, adding that the
Danish suspension was precautionary.

"Blood clots can occur naturally and are not uncommon," said
Phil Bryan, MHRA Vaccines Safety Lead, adding that more than 11
million doses of the vaccine had been administered across the UK
and that reports of blood clots were not greater than would have
occurred naturally.

"We are keeping this issue under close review but available
evidence does not confirm that the vaccine is the cause. People
should still go and get their COVID-19 vaccine when asked to do
so."

Austria earlier in the week halted a batch of the shot, but
the European Medicines Agency said on Wednesday there was no
evidence so far linking AstraZeneca's vaccine to illnesses in
two people who received it in Austria.
(Reporting by Alistair Smout; Editing by Giles Elgood)

Related Shares

More News
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the...

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the w...

27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation readin...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.